Sam Raha
Tracked across 2 events · 15 articles · First seen Jun 02, 2026 · Last active Aug 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Levi & Korsinsky, a securities litigation firm, commenced an investigation into Myriad Genetics, Inc. (Nasdaq: MYGN) for potential violations of federal securities laws. The investigation centers on Myriad's May 5, 2026 reaffirmation of full-year 2026…
Impact: Sam Raha, CEO, also reaffirmed guidance and expected sequential growth, which did not materialize; his statements are part of the investigation.
Aug 03, 2026 · 9 articles
Business
Impact: Sam Raha, CEO of Myriad Genetics, announced the appointment of Raj Jampa, highlighting his vision and experience as instrumental for the company's technology innovation and growth.
Jun 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sam Raha live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard